MALVERN, Pa., March 12, 2025 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH) in patients with Peyronie’s disease (PD) will be shared during the 89th annual meeting…

PLANO, Texas, March 12, 2025 /PRNewswire/ — Fortis, a payments technology leader for software providers, ERP customers, and scaling businesses announced today that it has received a joint investment from Audax Private Equity (“Audax”) and existing investor Lovell Minnick Partners (“LMP”)….

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.